A new study looks into whether all that crackling should be a wake-up call for your joint health. Here’s what to know about ...

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...

Study limitations included a lack of imaging at follow-up and a lack ... et al "Once-weekly semaglutide in persons with obesity and knee osteoarthritis" N Engl J Med 2024; DOI: 10.1056/NEJMoa2403664.

Further studies are required to fully comprehend the long-term clinical significance of MRI changes seen after platelet-rich plasma therapy for focal early knee osteoarthritis and how this varies ...

so that patients at highest risk can be identified and referred for advanced imaging without delay." Normally, patients with ...

Discover how blood flow restriction therapy enhances recovery for knee osteoarthritis patients, improving pain, strength, and ...

injections for osteoarthritis (OA) is still controversial. We investigated the effect of PRP injections in patients with knee OA based on decreasing pain, improving function, global assessment and ...

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of glucagon-like peptide-1 receptor agonists on outcomes in knee osteoarthritis ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.